Skip to main content
NIH funding notice PAR-18-830

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Closed on June 3, 2021.

Posted
June 14, 2018
Close date
June 3, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,591,477 in first-year total cost, median $489,616.

Most frequent study sections

  1. Cancer Molecular Pathobiology Study Section[CAMP]1
  2. Cellular, Molecular and Integrative Reproduction Study Section[CMIR]1
  3. Genomics, Computational Biology and Technology Study Section[GCAT]1
  4. Integrative and Clinical Endocrinology and Reproduction Study Section[ICER]1
  5. Pregnancy and Neonatology Study Section[PN]1

Most frequent institutions

  1. LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
  2. NORTHWESTERN UNIVERSITY AT CHICAGO1
  3. UNIV OF MASSACHUSETTS MED SCH WORCESTER1
  4. UNIVERSITY OF MARYLAND BALTIMORE1
  5. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
Competing awards under PAR-18-830 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Pathological reprogramming of the m6A epitranscriptome in uterine fibroids1R01HD106285-01AL-HENDY, AYMANBOYER, THOMAS GUNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX$661,325ICER
2021Regulation of tRNA fragment biogenesis and function by nucleotide modifications1R01HD099816-01A1MANDON, ELISABET CECILIARANDO, OLIVER JUNIV OF MASSACHUSETTS MED SCH WORCESTER, MA$489,616GCAT
2021A non-canonical role for EZH2 in rRNA methtlation1R01CA256741-01A1CAO, QINORTHWESTERN UNIVERSITY AT CHICAGO, IL$469,932CAMP
2020Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy1R01HD099843-01A1REECE, E. ALBERTSHEN, WEI-BINYANG, PEIXINUNIVERSITY OF MARYLAND BALTIMORE, MD$586,895PN
2020Epitranscriptomic regulation of spermatogenesis and male fertility1R01HD099924-01A1YAN, WEILUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA$383,709CMIR

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-830: The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) | ScienceDex | ConductScience